Browsing Infectious Diseases Institute (IDI) by Type
Now showing items 1-4 of 4
-
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial
(Elsevier, 2022-04-20)Background WHO guidelines recommend dolutegravir plus two nucleoside reverse transcriptase inhibitors (NRTIs) for second-line HIV therapy, with NRTI switching from first-line tenofovir to zidovudine. We aimed to ... -
Feasibility of virtual reality based training for optimising COVID-19 case handling in Uganda
(BMC Medical Education, 2022)Background: Epidemics and pandemics are causing high morbidity and mortality on a still-evolving scale exemplifed by the COVID-19 pandemic. Infection prevention and control (IPC) training for frontline health workers is ... -
A training for health care workers to integrate hepatitis B care and treatment into routine HIV care in a high HBV burden, poorly resourced region of Uganda: the ‘2for1’ project.
(BMC Medical Education, 2022)Introduction: The “2for1” project is a demonstration project to examine the feasibility and effectiveness of HBV care integrated into an HIV clinic and service. An initial phase in implementation of this project was the ... -
Using Intervention Mapping methodology to design an HIV linkage intervention in a refugee settlement in rural Uganda.
(AIDS Care, 2022)Nearly 80 million people have been forcibly displaced by persecution, violence, and disaster. Displaced populations, including refugees, face health challenges such as resource shortages, food and housing insecurity, ...